Publicaciones en colaboración con investigadores/as de University of Washington (6)

2021

  1. Considerations for treatment duration in responders to immune checkpoint inhibitors

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3

2020

  1. Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

    Cancer Cell, Vol. 38, Núm. 4, pp. 500-515.e3

2017

  1. Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

    The Lancet Oncology, Vol. 18, Núm. 10, pp. 1360-1372

  2. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

    Cell, Vol. 171, Núm. 4, pp. 934-949.e15

2016

  1. Factors Associated with Early Mortality in Patients Treated with Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 94, Núm. 3, pp. 612-620

2015

  1. Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis

    International Journal of Radiation Oncology Biology Physics, Vol. 91, Núm. 1, pp. 133-139